12.6 Patient monitoring

For patients on drug susceptible TB treatment, see Chapter 9.

For patients on multidrug-resistant or rifampicin-resistant TB treatment, see Chapter 10.

For patients on isoniazid-resistant TB treatment, see Chapter 11.